SEC Form 4 · accession 0001179110-16-023097
MOMENTA PHARMACEUTICALS INC · MNTA
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
John E Bishop
Officer — Senior VP, Pharmaceutical Scie
Period of report
Apr 13, 2016
Accepted (ET)
Apr 15, 2016 · 1:51 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001235010
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Apr 13, 2016 | A | 60,000 | $0.00 | A | 167,086 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Represents 60,000 shares of restricted common stock, $0.0001 par value per share, awarded pursuant to the Company's 2013 Stock Incentive Plan, as amended, and subject to a restricted stock agreement to be entered into between the Company and Mr. Bishop. Pursuant to the restricted stock agreement, the shares of restricted Common Stock shall vest on the achievement of certain company goals within a specified time period.